Kevin G. Lokay - Jun 15, 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Director
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Kevin G. Lokay
Stock symbol
GRTX
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/16/2022, 04:06 PM
Previous filing
Jun 17, 2021
Next filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +15K $0.00 15K Jun 15, 2022 Common Stock 15K $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of June 15, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.